NVNovartis AG NVSEF · OTC
$143.90 -0.29% (-$0.42)
- Market cap
- $292.6B
- Enterprise value
- $333.9B
- P/E
- 23.1x
- Forward P/E
- 16.9x
- PEG
- 0.9x
- P/S
- 5.3x
- P/FCF
- 18.3x
- EV/EBITDA
- 14.7x
- ROIC
- 13.7%
- Gross margin
- 74.3%
- Net margin
- 23.1%
- Dividend yield
- 3.08%
- Payout ratio
- 71.3%
- Net debt/EBITDA
- 1.8x
- Beta
- 0.49
- Free float
- 84.6%
About the company
Novartis AG is a Swiss multinational pharmaceutical company specializing in the development, manufacturing, and distribution of drugs and healthcare products. Founded in 1996 through the merger of Ciba-Geigy and Sandoz, the company is headquartered in Basel, Switzerland. Novartis focuses on treating a wide range of diseases, including cancer, cardiovascular conditions, neurological disorders, and more. The company is one of the largest global players in pharmaceutical research and development.
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Vasant Narasimhan
Employees
75,267
Headquarters
Basel
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number